Cyclin dependent kinase inhibiting purine derivatives

Method of treating a tumour or other cell proliferation disorder which comprises administering an effective amount of a purine compound which inhibits cyclic dependent kinase activity. Novel purine compounds and pharmaceutical compositions are also disclosed.

Saved in:
Bibliographic Details
Main Authors ROGER JOHN GRIFFIN, PHILIP JOHN JEWSBURY, DAVID RICHARD NEWELL, FRANCIS THOMAS BOYLE, MARTIN EDWARD MANTYLA NOBLE, JANE ANNE ENDICOTT, ALAN HILARY CALVERT, BERNHARD THOMAS GOLDING, NICOLA JANE CURTIN
Format Patent
LanguageEnglish
Published 08.02.1999
Edition6
Subjects
CHEMISTRY
DERIVATIVES THEREOF
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Online AccessGet full text

Cover

More Information
Summary:Method of treating a tumour or other cell proliferation disorder which comprises administering an effective amount of a purine compound which inhibits cyclic dependent kinase activity. Novel purine compounds and pharmaceutical compositions are also disclosed.
Bibliography:Application Number: AU19980082342